Omicron: Master of immune evasion maintains robust ACE2 binding

Signal Transduct Target Ther. 2022 Apr 7;7(1):118. doi: 10.1038/s41392-022-00965-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme 2* / genetics
  • Antibodies, Neutralizing
  • COVID-19 / immunology
  • COVID-19 / virology
  • Humans
  • Immune Evasion*
  • Neutralization Tests
  • SARS-CoV-2* / immunology

Substances

  • Antibodies, Neutralizing
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2